Cantitate/Preț
Produs
Total produse
Vezi coșul
Biomarkers for Alzheimer’s Disease Drug Development de Robert Perneczky

Biomarkers for Alzheimer’s Disease Drug Development: Methods in Molecular Biology, cartea 1750

Editat de Robert Perneczky
en Limba Engleză Hardback – 7 mar 2018
This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer’s disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer’s disease, cutting-edge developments in neuropathology and their relevance for Alzheimer’s disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.
 
Authoritative and cutting-edge, Biomarkers for Alzheimer's Disease Drug Development aims to ensure successful results in the further study of this vital field. 
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 54394 lei  38-44 zile
  Springer – 14 aug 2020 54394 lei  38-44 zile
Hardback (2) 79802 lei  43-57 zile
  Springer – 7 mar 2018 79802 lei  43-57 zile
  Springer Us – 2 mar 2024 110992 lei  38-44 zile

Din seria Methods in Molecular Biology

Preț: 79802 lei

Preț vechi: 84002 lei
-5% Nou

Puncte Express: 1197
Preț estimativ în valută:
15272€ • 15847$ • 12765£

Carte tipărită la comandă

Livrare economică 17-31 martie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781493977031
ISBN-10: 1493977032
Pagini: 330
Ilustrații: XV, 372 p. 54 illus., 45 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.89 kg
Ediția:1st ed. 2018
Editura: Springer
Colecția Humana
Seria Methods in Molecular Biology

Locul publicării:New York, NY, United States

Cuprins

Epidemiology of Dementia: The Burden on Society, the Challenges for Research.- Population-based Approaches to Alzheimer’s Disease Prevention.- Systems Biology Methods for Alzheimer’s Disease Research towards Molecular Signatures, Subtypes and Stages and Precision Medicine. Application in Cohort Studies and Trials.- CSF Lipidomics Analysis: High-Resolution Mass Spectrometry Analytical Platform.- CSF N-glycomics using MALDI MS Techniques in Alzheimer’s Disease.- MicroRNA Profiling of Alzheimer’s Disease Cerebrospinal Fluid.- Validation of a Chemiluminescence Immunoassay for Measuring  Amyloid-β in Human Blood Plasma.- Mass Spectrometry-based Metabolomic Multiplatform for Alzheimer’s Disease Research.- Blood-based Biomarker Screening with Agnostic Biological Definitions for an Accurate Diagnosis within the Dimensional Spectrum of Neurodegenerative Diseases.- Functional Magnetic Resonance Imaging in Alzheimer’ Disease Drug Development.- Neuroimaging Methods for MRI Analysis in CSF Biomarkers Studies.- Hybrid PET-MRI in Alzheimer’s Disease Research.- Amyloid PET Imaging: Standardization and Integration with Other Alzheimer Disease Biomarkers.- The use of 18F-FDG PET in the Diagnostic Workup of Alzheimer’s Dementia.- Quantification of Tau Load in Alzheimer’s Disease Clinical Trials Using Positron Emission Tomography.- Imaging Neuroinflammation: Quantification of Astrocytosis in a Multitracer PET Approach.- Unbiased Lipidomics and Metabolomics of Human Brain Samples.- Neuropathological Assessment as an Endpoint in Clinical Trial Design.- Analysis of micro-RNA Expression by qPCR on a Microfluidics Platform for Alzheimer’s Disease Biomarker Discovery.- Telomere length shortening in Alzheimer’s disease – procedures for a causal investigation using single nucleotide polymorphisms in a Mendelian Randomization study.- Quantifying miRNA Deregulation in Alzheimer’s Disease.- Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET.- In Vivo Two-photon Calcium Imaging of Hippocampal Neurons in Alzheimer Mouse Models.- Cognitive Assessment in Alzheimer’s Disease Clinical Trials.- Data Mining and Machine Learning Methods for Dementia Research. 

Textul de pe ultima copertă

This volume aims to build a new generation of experts with a broader understanding of key topics in the Alzheimer’s disease field. Chapters guide readers through innovative approaches to the discovery of novel biomarkers in cerebrospinal fluid, innovation in blood-based biomarkers, a comprehensive overview of magnetic resonance imaging and molecular imaging approaches and their value for developing drugs for Alzheimer’s disease, cutting-edge developments in neuropathology and their relevance for Alzheimer’s disease trials, novel genomic strategies for biomarker development, and related topics including neuropsychological testing and advanced analytical methods.Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.  
Authoritativeand cutting-edge, Biomarkers for Alzheimer's Disease Drug Development aims to ensure successful results in the further study of this vital field. 

Caracteristici

Includes cutting-edge methods and protocols Provides step-by-step detail essential for reproducible results Contains key notes and implementation advice from the experts